Eva Mamak

Neurocognition across the spectrum of mucopolysaccharidosis type I: Age, severity, and treatment

Elsa Shapiro, Igor Nestrašil, Kyle Rudser et al. · Molecular Genetics and Metabolism · 2015 · 68 citations · Full text

Medicine, Neurology, Neuroscience +11

Novel therapy for pyridoxine dependent epilepsy due to ALDH7A1 genetic defect: l-arginine supplementation alternative to lysine-restricted diet

Saadet Mercimek‐Mahmutoglu, Dawn Cordeiro, Vivian Rodriguez Cruz et al. · European Journal of Paediatric Neurology · 2014 · 67 citations

Medicine, Neuroscience, Pharmacology +15

Person Ability Scores as an Alternative to Norm-Referenced Scores as Outcome Measures in Studies of Neurodevelopmental Disorders

Cristan Farmer, Aaron J. Kaat, Audrey Thurm et al. · American Journal on Intellectual and Developmental Disabilities · 2020 · 62 citations · Full text

Education, Educational Assessment, Educational Measurement +17

Cognitive, medical, and neuroimaging characteristics of attenuated mucopolysaccharidosis type II

Brianna Yund, Kyle Rudser, Alia Ahmed et al. · Molecular Genetics and Metabolism · 2014 · 50 citations · Full text

Medicine, Neurology, Neuroscience +8

Seizure Burden and Neurologic Outcomes After Neonatal Encephalopathy

Huda M. Alharbi, Elana Pinchefsky, My-An Tran et al. · Neurology · 2023 · 41 citations · Full text

Medicine, Neurology, Pediatrics +17